These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33567957)

  • 21. Bulk and single-cell transcriptome reveal the immuno-prognostic subtypes and tumour microenvironment heterogeneity in HCC.
    Ji D; Lu S; Zhang H; Li Z; Wang S; Miao T; Jiang Z; Ao L
    Liver Int; 2024 Apr; 44(4):979-995. PubMed ID: 38293784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
    Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
    Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma.
    Pan B; Yang M; Wei X; Li W; Wang K; Yang M; Lu D; Wang R; Cen B; Xu X
    Aging (Albany NY); 2021 Jul; 13(14):18620-18644. PubMed ID: 34282055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genomic landscape of hepatocellular carcinoma subtypes with various proportions of nonleukocyte stromal cells.
    Peng J; Li C; Zhou J; Peng J; Wang C; Lai S; Guo S; Zhong Y; Deng L; Tang X
    Gene; 2020 Nov; 761():145028. PubMed ID: 32763490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making.
    Shi Y; Wang Y; Yang R; Zhang W; Zhang Y; Feng K; Lv Q; Niu K; Chen J; Li L; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1090324. PubMed ID: 36605944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma.
    Qian H; Song S; Tian Y; Qi L; Gao H; Yuan L
    Medicine (Baltimore); 2021 Apr; 100(15):e25374. PubMed ID: 33847635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
    Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
    Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
    Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
    World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential biomarkers for the prognosis and treatment of HCC immunotherapy.
    Li H; He Q; Zhou GM; Wang WJ; Shi PP; Wang ZH
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2027-2046. PubMed ID: 36930502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of correlation between high expression of nucleoporin 85 (NUP85) and immune cell infiltration in hepatocellular carcinoma].
    Liu X; Ding Z; Wu H; Ma J; Lu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jun; 40(6):508-519. PubMed ID: 38952090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
    Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
    Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma.
    Huang N; Zhang J; Kuang S; Li Z; Zhao H; Wu J; Liu M; Wang L
    Cancer Med; 2023 Apr; 12(7):8991-9004. PubMed ID: 36680322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characteristics of novel immune subtypes of HCC based on lncRNAs related to immune disorders.
    Zhang Q; Yu X; Zhang S; Guo W; He Y
    Sci Rep; 2022 May; 12(1):8905. PubMed ID: 35618810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma.
    Yin T; Zhao L; Yao S
    BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of RAC1-related immune and prognostic subtypes of hepatocellular carcinoma.
    Wang W; Xia H; Feng P; Dai B
    J Gene Med; 2024 Jul; 26(7):e3719. PubMed ID: 38979878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
    Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
    Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 40. Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma.
    Wang Z; Chen X; Zhang J; Chen X; Peng J; Huang W
    Front Immunol; 2023; 14():1204338. PubMed ID: 37680641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.